[Alpha-1-antitrypsin deficiency and renal involvement]

Area of Science:

• Nephrology
• Hepatology
• Immunology

Background:

• Alpha 1-antitrypsin deficiency (Pi Z) is a genetic disorder that can lead to liver disease.
• Cirrhosis is advanced liver scarring.
• Membranoproliferative glomerulonephritis is a type of kidney disease characterized by immune deposits in the glomeruli.

Observation:

• A young girl with alpha 1-antitrypsin deficiency (Pi Z), cirrhosis, hypocomplementemia, and proteinuria presented with type I membranoproliferative glomerulonephritis on renal biopsy.
• Renal biopsy revealed immune deposits containing IgA, IgG, IgM, C1q, C4, and C3, but notably, no alpha 1-antitrypsin.
• A literature review identified 10 similar cases, all exhibiting type I membranoproliferative glomerulonephritis.

Findings:

• The study identified a correlation between alpha 1-antitrypsin deficiency (Pi Z) with cirrhosis and type I membranoproliferative glomerulonephritis in a pediatric patient.
• Immune complex deposition in the glomeruli was observed, but alpha 1-antitrypsin was not detected within these deposits.
• All reported similar cases also presented with type I membranoproliferative glomerulonephritis, suggesting a consistent pathological pattern.

Implications:

• The findings suggest that chronic liver disease, potentially exacerbated by alpha 1-antitrypsin deficiency, may play a significant role in the pathogenesis of membranoproliferative glomerulonephritis.
• This highlights the importance of considering renal involvement in patients with alpha 1-antitrypsin deficiency and liver disease.
• Further research is warranted to elucidate the precise mechanisms linking hepatic disease to glomerular injury in this context.